SABRE是一种新的定量受体功能模型,它能够用单个统一的匹配量化受体结合,甚至从具有挑战性的度效应数据中量化受体结合
Barbara Olah1,2, Vera Tarjanyi3, Gabor Viczjan3
1Department of Orthodontics, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary.
Frontiers in pharmacology
|February 16, 2026
概括
信号放大,结合亲和力和受体激活效率 (SABRE) 模型被扩展到一个多线模型. 这种新模型可靠地分析功能数据,即使有不确定性,使用单一的全球匹配.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物物理学的生物物理.
- 数学建模的数学建模
背景情况:
- 信号放大,结合亲和力和受体激活效率 (SABRE) 模型为受体功能提供了定量框架.
- 现有的扩展允许从功能数据中确定平衡解离常数 (Kd) 和可操作的受体分数 (q).
研究的目的:
- 在SABRE框架内使用新开发的多线模型重新评估度效应数据.
- 评估多线模型对具有挑战性的数据集的可靠性和适用性.
主要方法:
- 应用了一个新的多线模型,集成到SABRE模型框架中.
- 使用单一的全球合适方法进行全面的数据分析.
- 评估复杂的,六个模型的全球适配,以获得最佳的适应性.
主要成果:
- 多线模型表现出可靠的性能,即使数据含有不确定性.
- 一个复杂的,六个模型的全球匹配对于分析的数据集证明是最有效的.
- 该模型通过统一的装配过程成功提供了一致的结果.
结论:
- 在SABRE框架内开发的多线模型提供了一个强大的方法来分析功能性受体数据.
- 准确地将SABRE模型方程与功能数据相匹配,对于可靠的结果至关重要.
- 这种方法增强了对受体药理学的定量理解.
相关概念视频
Quantitative Aspects of Drug-Receptor Interaction
1.8K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K
The Two-State Receptor Model
3.1K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.1K
The Equilibrium Binding Constant and Binding Strength
15.3K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.3K
Physiological Pharmacokinetic Models: Assumption with Protein Binding
280
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
280
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
34
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
34
Drug-Receptor Interactions
7.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.7K


